- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT07938190
Eating Habits and Behavior in People Affected by Lipodystrophy: Observational Study (lipo-diet_2024)
Title: Dietary Habits and Eating Behavior in People with Lipodystrophy: An Observational Study.
Purpose: The purpose of this study is to investigate and analyze the dietary habits and eating behaviors of patients diagnosed with lipodystrophy. Since there is currently a lack of specific data on how these patients approach nutrition, this research aims to provide essential information to improve nutritional guidelines. Additionally, the study seeks to understand if there is a relationship between eating behaviors and the patients' clinical data, such as blood test results and body measurements (anthropometric parameters).
Study Design:
This is an observational, cross-sectional, single-center study with a 2-year enrollment period. Participants will be recruited during their regular medical visits at the Endocrinology Unit of the IRCCS AOU di Bologna, Policlinico Sant'Orsola.
During the study, the following activities will take place:
Clinical Data Collection: Researchers will record body measurements and blood test results as part of standard clinical practice.
Questionnaires: Patients will be asked to complete four specific questionnaires (available in Italian and English) regarding their food frequency, eating behavior patterns, tendencies toward orthorexia, and physical activity levels.
Format: These questionnaires can be completed electronically via a RedCap link (taking approximately 20-30 minutes) or on paper.
Eligibility:
Inclusion Criteria: Adults (18 years or older) with a confirmed diagnosis of lipodystrophy who provide informed consent.
Exclusion Criteria: Patients with HIV-related lipodystrophy or those who cannot understand the languages in which the questionnaires are provided.
Duration and Participation:
The study will last a total of 2 years and 6 months. The first 2 years are dedicated to patient selection and recruitment, followed by 6 months for data analysis. The researchers aim to enroll 30 participants.
Aperçu de l'étude
Statut
Les conditions
Description détaillée
1. Background and RationaleLipodystrophy refers to a rare and heterogeneous group of syndromes characterized by the total or partial loss of subcutaneous adipose tissue. This condition leads to severe metabolic complications, such as marked insulin resistance, early-onset diabetes, severe hypertriglyceridemia, and hepatic steatosis (fatty liver).A key factor in this pathology is hypoleptinemia (deficiency of the hormone leptin), which plays a crucial role in regulating energy balance. The lack of leptin disrupts satiety signals, often resulting in hyperphagia (insatiable hunger), with energy intake potentially exceeding requirements by up to 40%. While lifestyle and dietary modifications are considered the "cornerstone" of treatment, there is currently a significant lack of structured data and evidence-based nutritional guidelines for these patients.2. Study ObjectivesPrimary Objective: To identify, analyze, and describe the lifestyle of patients with a focus on dietary habits, eating behaviors, and physical activity.Secondary Objective: To explore the relationship between these behaviors and clinical data, including anthropometric measurements and biochemical (blood) parameters.3. Study Population and EligibilityThe study aims to enroll 30 patients managed at the Endocrinology Unit of the IRCCS AOU di Bologna, Policlinico Sant'Orsola.Inclusion Criteria: Male and female adults (≥ 18 years old) with a confirmed diagnosis of lipodystrophy who provide written informed consent.Exclusion Criteria: Patients with HIV-related lipodystrophy or those unable to understand the languages in which the questionnaires are provided.4. Study Design and MethodologyThis is a prospective, cross-sectional, observational, single-center study. Data will be collected during routine endocrinological visits through the following means:A. Clinical and Biochemical ParametersAnthropometric Data: Weight, height, BMI, waist and hip circumference, and body fat percentage.Biochemical Data: Fasting plasma glucose, HbA1c, full lipid profile (total cholesterol, HDL, LDL, triglycerides), liver enzymes (AST, ALT), kidney function, insulin levels, and HOMA-IR.B. Self-Assessment QuestionnairesParticipants will complete four validated tools (estimated time: 30 minutes, via RedCap or paper):Food Frequency Questionnaire (FFQ): To assess the intake frequency of 36 food items over the past 12 months.Three-Factor Eating Questionnaire (TFEQ-R18): To evaluate cognitive restraint, uncontrolled eating, and emotional eating.Teruel Orthorexia Scale (TOS): To measure orthorexic tendencies (obsession with healthy eating) in both "healthy" and "nervosa" dimensions.IPAQ-Short Form: To categorize physical activity levels as low, moderate, or high.5. Study Duration and AnalysisThe total study duration is 2 years and 6 months. This includes 2 years for patient recruitment and 6 months for data analysis. Statistical analysis will be performed using STATA 19 SE, comparing the observed dietary data with the 2024 LARN guidelines (Nutrient and Energy Reference Intake Levels) to identify deviations and correlations with metabolic health.
Type d'étude
Inscription (Estimé)
Contacts et emplacements
Coordonnées de l'étude
- Nom: Carolina Poli, nutritionist
- Numéro de téléphone: 0512094676
- E-mail: carolina.poli@aosp.bo.it
Lieux d'étude
-
-
Bologna
-
Bologna, Bologna, Italie, 40138
- Recrutement
- IRCSS Azienda Ospedaliero-Universitaria di Bologna
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
Méthode d'échantillonnage
Population étudiée
Male and female patients over the age of 18 attending the outpatient service of the Endocrinology and Diabetes Prevention and Treatment Unit - U. Pagotto - IRCCS AOU in Bologna, Policlinico Sant'Orsola - Malpighi during their visit to the dedicated clinic.
La description
Inclusion Criteria:
- Obtaining informed consent
- Age 18 or older at the time of diagnosis
- Diagnosis of lipodystrophy
Exclusion Criteria:
- Failure to understand the language in which the questionnaires are administered
- HIV-related lipodystrophy
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Modèles d'observation: COHORT
- Perspectives temporelles: PROSPECTIVE
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Food Frequency Questionnaire (FFQ)
Délai: baseline
|
baseline
|
|
|
Three-Factor Eating Questionnaire R-18 (TFEQ-R18)
Délai: baseline
|
Assessment of eating behavior using the 18-item validated questionnaire, evaluating three subscales: Cognitive Restraint (CR), Uncontrolled Eating (UE), and Emotional Eating (EE). Items are scored on a 4-point scale and converted to a 0-100 scale per domain, where higher scores indicate higher expression of the specific behavior. |
baseline
|
|
Teruel Orthorexia Scale (TOS)
Délai: baseline
|
baseline
|
|
|
International Physical Activity Questionnaire - Short Form (IPAQ-Short Form)
Délai: baseline
|
baseline
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Body Mass Index (BMI)
Délai: baseline
|
Assessment of body weight status using BMI, calculated as weight in kilograms divided by height in meters squared (kg/m2). |
baseline
|
|
Body Fat Percentage
Délai: baseline
|
Evaluation of total body fat composition measured via anthropometric assessment/bioelectrical impedance analysis (BIA). |
baseline
|
|
Waist-to-Hip Ratio (WHR)
Délai: baseline
|
Assessment of abdominal obesity calculated as waist circumference divided by hip circumference. |
baseline
|
|
Fasting Blood Glucose
Délai: baseline
|
Laboratory evaluation of serum/plasma fasting glucose concentration (mg/dL). |
baseline
|
|
Glycated Hemoglobin (HbA1c)
Délai: baseline
|
Laboratory evaluation of glycated hemoglobin level (mmol/mol). |
baseline
|
|
Fasting Serum Insulin
Délai: baseline
|
Laboratory evaluation of basal insulin levels micromol/mL. |
baseline
|
|
Homeostatic Model Assessment for Insulin Resistance (HOMA-IR)
Délai: baseline
|
index score |
baseline
|
|
Lipid Profile Parameters
Délai: baseline
|
baseline
|
Collaborateurs et enquêteurs
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Réel)
Achèvement primaire (Estimé)
Achèvement de l'étude (Estimé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- lipo-diet_2024
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .